OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ISHA57

Ishan Dyes and Chemicals Ltd

Specialty ChemicalsVerified

Ishan Dyes and Chemicals Ltd has a debt-to-equity ratio of 0.89, indicating a moderate level of leverage, and a current ratio of 0.99, suggesting limited short-term liquidity cushion. The company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, signaling potential refinancing risk in the near term. The company's profitability metrics are below industry norms, with a return on equity (ROE) of 1.04% and a return on assets (ROA) of 0.49%. These figures are significantly lower than the industry_config preferred metrics for Specialty Chemicals, which typically require ROE above 10% and ROA above 5% to be considered competitive. The operating margin of 4.19% (calculated from operating income of INR 42.53 million on revenue of INR 1.01 billion) is also below the median for the cohort. The company operates through a single segment, Chemicals, and is concentrated in India, with no disclosed international revenue. This geographic concentration increases exposure to local economic and regulatory risks, including currency fluctuations and domestic demand volatility. The lack of diversification in both product and geographic markets is a structural risk. The company's revenue growth is expected to remain flat in the current fiscal year, with a marginal increase in the next fiscal year. Historical revenue growth has been modest, and the outlook is constrained by weak demand in downstream industries such as paints and textiles. The capital expenditure of INR 421.41 million in the latest period reflects ongoing investment in production capacity, but the free cash flow of INR -385.90 million indicates that the company is not generating sufficient cash to fund operations and investments without external financing. The risk assessment highlights liquidity as a medium concern, with the company's cash and equivalents of INR 1.43 million being insufficient to cover short-term obligations. The dilution risk is assessed as low, with no recent share issuance or shelf registration activity reported. However, the company's reliance on long-term debt (INR 920.93 million) and negative free cash flow could necessitate future equity or debt financing, which may dilute existing shareholders. Recent filings and transcripts do not indicate any material events or strategic shifts. The company continues to focus on its core chemical manufacturing business, with no disclosed M&A activity or new product launches in the latest reporting period. The absence of significant strategic developments suggests a conservative operational approach.

30-day price · ISHA+12.10 (+23.8%)
Low$47.05High$71.99Close$62.93As of17 May, 00:00 UTC
Profile
CompanyIshan Dyes and Chemicals Ltd
TickerISHA.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Ishan Dyes and Chemicals Ltd is engaged in the manufacturing, trading, and export of chemicals used in dyes and pigments, primarily copper phthalocyanine crude blue (CPC Blue) and pigment blues, which are used in paints, textiles, inks, plastics, and rubber industries.

Classification. Ishan Dyes and Chemicals Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Ishan Dyes and Chemicals Ltd has a debt-to-equity ratio of 0.89, indicating a moderate level of leverage, and a current ratio of 0.99, suggesting limited short-term liquidity cushion. The company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, signaling potential refinancing risk in the near term. The company's profitability metrics are below industry norms, with a return on equity (ROE) of 1.04% and a return on assets (ROA) of 0.49%. These figures are significantly lower than the industry_config preferred metrics for Specialty Chemicals, which typically require ROE above 10% and ROA above 5% to be considered competitive. The operating margin of 4.19% (calculated from operating income of INR 42.53 million on revenue of INR 1.01 billion) is also below the median for the cohort. The company operates through a single segment, Chemicals, and is concentrated in India, with no disclosed international revenue. This geographic concentration increases exposure to local economic and regulatory risks, including currency fluctuations and domestic demand volatility. The lack of diversification in both product and geographic markets is a structural risk. The company's revenue growth is expected to remain flat in the current fiscal year, with a marginal increase in the next fiscal year. Historical revenue growth has been modest, and the outlook is constrained by weak demand in downstream industries such as paints and textiles. The capital expenditure of INR 421.41 million in the latest period reflects ongoing investment in production capacity, but the free cash flow of INR -385.90 million indicates that the company is not generating sufficient cash to fund operations and investments without external financing. The risk assessment highlights liquidity as a medium concern, with the company's cash and equivalents of INR 1.43 million being insufficient to cover short-term obligations. The dilution risk is assessed as low, with no recent share issuance or shelf registration activity reported. However, the company's reliance on long-term debt (INR 920.93 million) and negative free cash flow could necessitate future equity or debt financing, which may dilute existing shareholders. Recent filings and transcripts do not indicate any material events or strategic shifts. The company continues to focus on its core chemical manufacturing business, with no disclosed M&A activity or new product launches in the latest reporting period. The absence of significant strategic developments suggests a conservative operational approach.
Key takeaways
  • Ishan Dyes and Chemicals Ltd has a moderate debt load and limited liquidity, with a current ratio of 0.99.
  • The company's profitability is below industry norms, with ROE of 1.04% and ROA of 0.49%.
  • Geographic and product concentration in India and chemical manufacturing increases exposure to local demand and regulatory risks.
  • Free cash flow is negative, and capital expenditures are high, indicating a need for external financing.
  • The company has not disclosed any recent strategic initiatives or M&A activity.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.01B
Gross profit$230.6M
Operating income$42.5M
Net income$10.8M
R&D
SG&A
D&A
SBC
Operating cash flow$116.1M
CapEx-$421.4M
Free cash flow-$385.9M
Total assets$2.22B
Total liabilities$1.18B
Total equity$1.04B
Cash & equivalents$1.4M
Long-term debt$920.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.04B
Net cash-$919.5M
Current ratio1.0
Debt/Equity0.9
ROA0.5%
ROE1.0%
Cash conversion10.7%
CapEx/Revenue-41.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricISHAActivity
Op margin4.2%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.1%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin22.7%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-41.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity89.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 06:57 UTC#482ecc5d
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 06:58 UTCJob: c09ecdb9